Use of vascular endothelial growth factor to treat photoreceptor cells
US7223724B1 · kind B1 · utility
17Cited by
31References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 7, 2000 |
| Grant date | May 29, 2007 |
| Priority date | — |
| Expiry date | Feb 7, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/026
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to VEGF-2 polynucleotides and polypeptides and methods of using such polynucleotides and polypeptides. In particular, provided are methods of treating retinal disorders with VEGF-2 polynucleotides and polypeptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.